Special Situations Funds

Total investments

12

Average round size

40M

Portfolio companies

11

Lead investments

2

Follow on index

0.08

Exits

8

Stages of investment
Early Stage Venture
Areas of investment
BiotechnologyInformation ServicesMachine LearningHealth CareHealth DiagnosticsMedical DeviceMedicalTherapeuticsBiopharmaWearables

Summary

The leading representative office of defined VC is situated in the New York. The fund was located in North America if to be more exact in United States.

The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Special Situations Funds, startups are often financed by Intel Capital, Village Ventures, Toppan Printing. The meaningful sponsors for the fund in investment in the same round are venBio Partners, Venrock, Toppan Printing. In the next rounds fund is usually obtained by HV Holtzbrinck Ventures, Toronto Dominion Bank Group, Penguin Random House.

Among the various public portfolio startups of the fund, we may underline Digital Guardian, Audible, IZEA We can highlight the next thriving fund investment areas, such as Biopharma, Security. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. The fund has exact preference in some founders of portfolio startups.

The higher amount of exits for fund were in 2011. Speaking about the real fund results, this VC is 6 percentage points less often commits exit comparing to other organizations. The important activity for fund was in 2013. The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars. Comparing to the other companies, this Special Situations Funds performs on 42 percentage points more the average number of lead investments.

Show more

Investments analytics

Analytics

Total investments
12
Lead investments
2
Exits
8
Follow on index
0.08
Investments by industry
  • Biotechnology (3)
  • Medical Device (2)
  • Therapeutics (2)
  • Biopharma (2)
  • Medical (2)
  • Show 36 more
Investments by region
  • United States (9)
  • Canada (2)
  • Israel (1)
Peak activity year
2013

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
17
Avg. valuation at time of investment
727K
Group Appearance index
0.58
Avg. company exit year
12

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
E Ink 08 Oct 2007 Manufacturing, Hardware, Electronics Early Stage Venture 16M United States, Massachusetts, Cambridge

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.